:

Homeland Security

Emergent BioSolutions Acquires VaxGen’s Anthrax Vaccine Technology

DDN

Wednesday, May 14th, 2008

SHARE:

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…

Congress

House Republicans’ Blueprint For Reconciliation 3.0 Includes $60 Billion For Defense

House Republicans on Wednesday unveiled a blueprint for a third reconciliation bill that includes $60 billion for defense, a figure slightly below the Trump administration’s request to cover Iran war […]

Congress

Senate Dems Block Consideration Of FY ‘27 NDAA Over Iran War Concerns

Senate Democrats on Tuesday blocked a vote to advance consideration of the chamber’s $1.14 trillion fiscal year 2027 National Defense Authorization (NDAA). The procedural vote was 46-50, failing to reach […]

Congress

Concerns Raised At SASC Hearing On Unobligated Reconciliation Funds And Lack Of Updates On Iran War Cost

Members of the Senate Armed Services Committee (SASC) raised concerns at a hearing on Tuesday about the majority of funds in the $153 billion first reconciliation bill being unobligated thus […]

Unmanned Systems

CBO Says Upfront Costs To Protect Military Installations From Drones Between $1 Million And $74 Million

The initial costs to acquire and deploy counter-small unmanned aircraft system (C-sUAS) defenses at individual Defense Department installations are estimated at between $1.2 million and $73.6 million depending on the […]